MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and ...
Rates of leg and foot amputations in Illinois hospitals increased 65% between 2016 and 2023, reports a new Northwestern Medicine study. Men, Black patients, and those living in areas with low ...
New device expands AtriCure’s market opportunity in post-operative pain management while addressing a significant unmet clinical need Recently cleared under an FDA 510(k), the cryoXT device is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results